Skip to content
DraconiticResearch
Search Sources API
185,139 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1078 Mutational signatures as mechanistic biomarkers of tumor immunity: associations with TMB, PD-L1 and immune phenotypes across cancer types

  1. 1Boehringer Ingelheim GmbH, Biberach an der Riß, Baden-Württemberg, Germany
  2. 2Institute for Applied Science and Health, Applied University Coburg, Coburg, Bavaria, Germany

Related

  1. Germline structural variation involving gynecologic and breast cancers reveals polygenic signatures of tumor mutational load
    Fengju Chen, Yiqun Zhang, Luis F. Paulin +2
    Genome BiologyPeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  2. Chromosomal mutational signatures of DNA damaging agents at single cell resolution
    M. Andronescu, A. Adrian-Hamazaki, D. B. Yap +30
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Global evolutionary dynamics of peste des petits ruminants virus reveals geographic lineage structuring and clade-defining mutational signatures
    Sarowar Haque, Md. Mahfuj Islam, Anupam Das +11
    Frontiers in microbiologyPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  4. Sepsis-associated endothelial dysfunction: clinical phenotypes, biomarkers, bedside evidence, and translational implications
    Song Qin, Ninan Dai, Fengyun Xu +2
    The Journal of clinical investigationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Blood Cytokine Profiling Reveals Distinct Inflammatory Signatures in Phenotypes A and B of Polyendocrine Metabolic Ovarian Syndrome (PMOS; formerly PCOS).
    L. P. Patra, B. S. Johnson, K. P. Jayakrishnan +2
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv
BibTeX
@article{nath20261078,
  title = {{1078 Mutational signatures as mechanistic biomarkers of tumor immunity: associations with TMB, PD-L1 and immune phenotypes across cancer types}},
  author = {Neetika Nath and Stefan Simm},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1078},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1078},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1078 Mutational signatures as mechanistic biomarkers of tumor immunity: associations with TMB, PD-L1 and immune phenotypes across cancer types
AU  - Neetika Nath
AU  - Stefan Simm
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1078
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1078
SN  - 2051-1426
ER  -